Foresite Capital Management Iv, LLC

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 5Value: $111.1MLatest: 2025Q1

Foresite Capital Management IV, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 5 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "RLAY",
  "PHVS",
  "LYEL",
  null,
  "KURA"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 5
Total Value: 111069074
Accession Number: 0001104659-25-049390
Form Type: 13F-HR
CIK: foresite-capital-management-iv
Manager Name: Foresite-Capital-Management-Iv

Data Enrichment

80% identified

4 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

5 positions • $111.1M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

Pharvaris N.V.

PHVS|N69605108

Shares:4.4M

Value:$69.2M

% of Portfolio:62.3% ($69.2M/$111.1M)

578784100

Shares:2.1M

Value:$23.3M

% of Portfolio:20.9% ($23.3M/$111.1M)

Lyell Immunopharma, Inc.

LYEL|55083R104

Shares:16.0M

Value:$8.6M

% of Portfolio:7.8% ($8.6M/$111.1M)

Kura Oncology, Inc.

KURA|50127T109

Shares:1.1M

Value:$7.3M

% of Portfolio:6.6% ($7.3M/$111.1M)

Relay Therapeutics, Inc.

RLAY|75943R102

Shares:1.0M

Value:$2.6M

% of Portfolio:2.4% ($2.6M/$111.1M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Pharvaris N.V.(PHVScusipN69605108)	4.4M	QoQ +0.28% (-12.7K) YoY +9.20% (-371.7K)	All Managers (Combined)	$69.2M	62.3% ($69.2M/$111.1M)	QoQ -17.86% (-$15.1M) YoY -25.81% (-$24.1M)
(cusip578784100)✕	2.1M	QoQ NEW(+2.1M) YoY NEW(+2.1M)	All Managers (Combined)	$23.3M	20.9% ($23.3M/$111.1M)	QoQ NEW(+$23.3M) YoY NEW(+$23.3M)
Lyell Immunopharma, Inc.(LYELcusip55083R104)	16.0M	QoQ +92.28% (+7.7M) YoY +92.28% (-7.7M)	All Managers (Combined)	$8.6M	7.8% ($8.6M/$111.1M)	QoQ +61.64% (+$3.3M) YoY -53.60% (-$10.0M)
Kura Oncology, Inc.(KURAcusip50127T109)	1.1M	QoQ -35.61% (-615.0K) YoY -39.89% (-738.1K)	All Managers (Combined)	$7.3M	6.6% ($7.3M/$111.1M)	QoQ -51.21% (-$7.7M) YoY -81.40% (-$32.1M)
Relay Therapeutics, Inc.(RLAYcusip75943R102)	1.0M	QoQ 0.00% (-0) YoY NEW(+1.0M)	All Managers (Combined)	$2.6M	2.4% ($2.6M/$111.1M)	QoQ -36.40% (-$1.5M) YoY NEW(+$2.6M)